<DOC>
	<DOCNO>NCT01219790</DOCNO>
	<brief_summary>This study determine delay neurotoxicity ( 12 month ) hypofractionated high dose irradiation ( 3 Gy x 9 ) associate zoledronic acid . The administration zoledronic acid repeat dosage define Authorisation Market . All patient receive total dose 27 Gy divide 3 fraction 9 Gy perform least 48 hour apart , treatment J1 , J3 J5 .</brief_summary>
	<brief_title>ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose Bone Metastases Vertebral Prostate Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Adenocarcinoma prostate metastatic Age &gt; 18 years3 . Life expectancy &gt; 12 month ; Performance Index status &lt; 3 PSA ≥ 4 ng / ml Zoledronic acid treatment progress recommend Authority Marketing Creatinine clearance 30 ml / min Lack maintenance cause disable pain lie long ( 30 minute ) No history radiotherapy region irradiate Absence neurological sign compression Distance metastasis spinal cord ≥ 5 mm Absence metastases unstable metastatic epidural spinal cord compression may require surgery radiotherapy Concomitant treatment drug testing , participation another clinical trial within &lt; 30 day Presence central system nervous desease ( symptoms progressive ) , Patient severe neurological disease , current manifestation peripheral neuropathy &gt; grade 2 NCICTC V4 Existence another severe pulmonary disease , liver kidney , digestive likely exacerbated treatment , Untreated zoledronic acid Treatment bisphosphonate Zoledronic acid Clinically significant hypersensitivity zoledronic acid , bisphosphonates excipients formulation Zometa . Creatinine clearance 30 ml / min History another primary cancer ( except basal cell skin cancer ) Or demented patient alter mental status obtain informed consent . / Persons deprive liberty guardianship Pain result maintain prolonged supine position ( 30 minute ) PSA 4 ng / ml History radiotherapy localize tumor site Distance metastasis spinal cord &lt; 5 mm Monitoring impossible psychological , sociological geographical distance .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Patients painful vertebral metastasis prostate cancer indication analgesic treatment .</keyword>
</DOC>